Clinical-pharmacological strategies to assess drug interaction potential during drug development (Q34417621)

2 August 2017

1 reference

title

Clinical-pharmacological strategies to assess drug interaction potential during drug development (English)

1 reference

2 August 2017

1 reference

J Kuhlmann

1

1 reference

PubMed ID

11676300

2 August 2017

W Mück

series ordinal

2

1 reference

2 August 2017

1 January 2001

1 reference

2 August 2017

1 reference

2 August 2017

24

1 reference

2 August 2017

10

1 reference

2 August 2017

715-725

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200124100-00001

2 August 2017

0 references

cites work

Are medication record cards useful?

1 reference

12 December 2020

Rational assessment of the interaction profile of cerivastatin supports its low propensity for drug interactions

1 reference

12 December 2020

From the Food and Drug Administration

1 reference

12 December 2020

Drug interactions that matter. A critical reappraisal

1 reference

12 December 2020

FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling.

1 reference

12 December 2020

Surveillance of drug therapy in the hospital

1 reference

12 December 2020

Sorivudine and 5-fluorouracil; a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase

1 reference

12 December 2020

An approach to the assessment of therapeutic drug interactions with fixed combination drug products

1 reference

12 December 2020

Assessment of adverse reactions within a drug surveillance program

1 reference

12 December 2020

Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.

1 reference

12 December 2020

Drug-related hospital admissions

1 reference

12 December 2020

Drug-induced illness as a cause for admission to a community hospital

1 reference

12 December 2020

["Clinically significant" new drug interactions]

1 reference

12 December 2020

Iatrogenic illness on a general medical service at a university hospital

1 reference

12 December 2020

DRUG TOXICITY IN MAN: THE PROBLEM AND THE CHALLENGE

1 reference

12 December 2020

Quantitative drug interactions prediction system (Q-DIPS): a computer-based prediction and management support system for drug metabolism interactions.

1 reference

12 December 2020

Acute admissions to a geriatric assessment unit

1 reference

12 December 2020

Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes

1 reference

12 December 2020

In vitro metabolic interaction studies: experience of the Food and Drug Administration

1 reference

12 December 2020

In vitro approaches to predicting drug interactions in vivo.

1 reference

12 December 2020

Rhabdomyolysis due to interaction of simvastatin with mibefradil

1 reference

12 December 2020

Adverse reactions to prescribed drugs in the elderly: a multicentre investigation

1 reference

12 December 2020

Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin

1 reference

12 December 2020

Drug-drug interactions of new active substances: mibefradil example

1 reference

12 December 2020

Torsades de pointes occurring in association with terfenadine use

1 reference

12 December 2020

1 reference

12 December 2020

Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use

1 reference

12 December 2020

Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor

1 reference

12 December 2020

Adverse drug interactions

1 reference

12 December 2020

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

1 reference

12 December 2020

Drug interactions in the elderly. How multiple drug use increases risk exponentially

1 reference

12 December 2020

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

12 December 2020

Clinical pharmacokinetics of mibefradil

1 reference

12 December 2020

Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population

1 reference

12 December 2020

Systematic screening for pharmacokinetic interactions during drug development

1 reference

12 December 2020

Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population

1 reference

12 December 2020

Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility

1 reference

12 December 2020

A fatal drug interaction between clozapine and fluoxetine

1 reference

12 December 2020

Computer based prescribing

1 reference

12 December 2020

THE HAZARDS OF HOSPITALIZATION

1 reference

12 December 2020

Drugs--remarkably nontoxic.

1 reference

12 December 2020

Assessment of the quality and quantity of drug-drug interaction studies in recent NDA submissions: study design and data analysis issues

1 reference

12 December 2020

Lack of pharmacokinetic interaction as an equivalence problem

1 reference

12 December 2020

Drug interaction studies during drug development: which, when, how?

1 reference

12 December 2020

Clinical pharmacokinetics of cerivastatin

1 reference

12 December 2020

Potential Drug Interactions in an Ambulatory Geriatric Population

1 reference

12 December 2020

Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group

1 reference

12 December 2020

Patient-oriented strategies for the prevention of drug interactions

1 reference

12 December 2020

[Pharmacodynamic interactions between drugs]

1 reference

12 December 2020

The influence of information provided by patients on the accuracy of medication records

1 reference

12 December 2020

10.2165/00002018-200124100-00001

Identifiers

DOI

1 reference

PubMed ID

11676300

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

11676300